Acknowledgments This work was supported by the British Heart Foundation Intermediate Basic Research Fellowship FS/09/026/27398 to NM., the Biotechnology and Biological Sciences Research Council doctoral training grant awarded to GDM and the Wellcome Trust and the University of Aberdeen ISSF Fund to NM and LG and The Royal Society (of London) to NM. SRT, BHM, MKD and PDW gratefully acknowledge Highlands and Islands Enterprise, Scottish Funding Council and the European Regional Development Fund for financial support. The authors thank Tonya Martin (Johnson & Johnson, New Brunswick, NJ), and Urs Thurneer (Cilag AG, Schaffhausen, Switzerland) for the generous gift of Fenretinide to use completely without restriction or obligation. The authors t...
Aim. Fenretinide, a synthetic retinoid derivative first investigated for cancer prevention and treat...
sity, insulin resistance, and hepatic steatosis. Am J Physiol Endocrinol Metab 297: E1420–E1429, 200...
<div><p>The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-HPR) has been dem...
Acknowledgments This work was supported by the British Heart Foundation Intermediate Basic Research ...
AbstractFenretinide (FEN) is a synthetic retinoid that inhibits obesity and insulin resistance in hi...
Fenretinide is a synthetic retinoid that can prevent obesity and improve insulin sensitivity in mice...
Copyright © 2014. Published by Elsevier Inc. Acknowledgments This work was supported by the British ...
Fenretinide is a synthetic retinoid that can prevent obesity and improve insulin sensitivity in mice...
Acknowledgements This study was supported by funds from the British Heart Foundation (PG16/90/32518)...
The authors would like to thank undergraduate student Aleksandra Kowalczuk (University of Aberdeen) ...
Aim. Fenretinide, a synthetic retinoid derivative first investigated for cancer prevention and treat...
sity, insulin resistance, and hepatic steatosis. Am J Physiol Endocrinol Metab 297: E1420–E1429, 200...
<div><p>The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-HPR) has been dem...
Acknowledgments This work was supported by the British Heart Foundation Intermediate Basic Research ...
AbstractFenretinide (FEN) is a synthetic retinoid that inhibits obesity and insulin resistance in hi...
Fenretinide is a synthetic retinoid that can prevent obesity and improve insulin sensitivity in mice...
Copyright © 2014. Published by Elsevier Inc. Acknowledgments This work was supported by the British ...
Fenretinide is a synthetic retinoid that can prevent obesity and improve insulin sensitivity in mice...
Acknowledgements This study was supported by funds from the British Heart Foundation (PG16/90/32518)...
The authors would like to thank undergraduate student Aleksandra Kowalczuk (University of Aberdeen) ...
Aim. Fenretinide, a synthetic retinoid derivative first investigated for cancer prevention and treat...
sity, insulin resistance, and hepatic steatosis. Am J Physiol Endocrinol Metab 297: E1420–E1429, 200...
<div><p>The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-HPR) has been dem...